Cholesterol depletion affects caveolin-1 expression, migration and invasion of oral tongue squamous cell carcinoma cell lines.

[1]  C. T. Vincent,et al.  Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer , 2021, Frontiers in Cell and Developmental Biology.

[2]  P. Matarrese,et al.  Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity? , 2021, Frontiers in Cell and Developmental Biology.

[3]  B. Cheng,et al.  Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities , 2020, International journal of cancer.

[4]  A. Mäkitie,et al.  Mass Spectrometry–Based Lipidomics of Oral Squamous Cell Carcinoma Tissue Reveals Aberrant Cholesterol and Glycerophospholipid Metabolism — A Pilot Study , 2020, Translational oncology.

[5]  A. Quest,et al.  Cell Intrinsic and Extrinsic Mechanisms of Caveolin-1-Enhanced Metastasis , 2019, Biomolecules.

[6]  M. Masařík,et al.  Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review , 2019, Molecular Cancer.

[7]  E. Furth,et al.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.

[8]  R. Tuan,et al.  Influence of cholesterol/caveolin-1/caveolae homeostasis on membrane properties and substrate adhesion characteristics of adult human mesenchymal stem cells , 2018, Stem cell research & therapeutics.

[9]  Z. Jaafari-Ashkavandi,et al.  Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma. , 2017, Pathology, research and practice.

[10]  T. Nonaka,et al.  Predictive Significance of Tumor Depth and Budding for Late Lymph Node Metastases in Patients with Clinical N0 Early Oral Tongue Carcinoma , 2017, Head and Neck Pathology.

[11]  Z. Nwosu,et al.  Caveolin-1 in the regulation of cell metabolism: a cancer perspective , 2016, Molecular Cancer.

[12]  H. Levine,et al.  Clinical Medicine , 1997 .

[13]  H. Emonard,et al.  Cellular Cholesterol Distribution Influences Proteolytic Release of the LRP-1 Ectodomain , 2016, Front. Pharmacol..

[14]  T. Salo,et al.  A novel human leiomyoma tissue derived matrix for cell culture studies , 2015, BMC Cancer.

[15]  David R. Jones,et al.  Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. , 2015, Chest.

[16]  T. Salo,et al.  Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study , 2015, BMC Cancer.

[17]  S. Routray Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview , 2014, Tumor Biology.

[18]  R. Lipowsky Remodeling of membrane compartments: some consequences of membrane fluidity , 2014, Biological chemistry.

[19]  S. Routray,et al.  Cancer Stem Cells Accountability in Progression of Head and Neck Squamous Cell Carcinoma: The Most Recent Trends! , 2014, Molecular biology international.

[20]  T. Teknos,et al.  Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. , 2013, Oral oncology.

[21]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[22]  R. Muraro,et al.  Caveolin‐1 overexpression is associated with simultaneous abnormal expression of the E‐cadherin/α–β catenins complex and multiple erbb receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas , 2012, Journal of cellular physiology.

[23]  X. Chen,et al.  Expression of Caveolin-1 in tongue squamous cell carcinoma by quantum dots , 2010, European journal of histochemistry : EJH.

[24]  T. Salo,et al.  A novel organotypic model mimics the tumor microenvironment. , 2009, The American journal of pathology.

[25]  Toshihide Kobayashi,et al.  Cholesterol regulation of rab-mediated sphingolipid endocytosis , 2009, Glycoconjugate Journal.

[26]  I. Parmryd,et al.  Cholesterol homeostasis in T cells. Methyl-beta-cyclodextrin treatment results in equal loss of cholesterol from Triton X-100 soluble and insoluble fractions. , 2008, Biochimica et biophysica acta.

[27]  V. Torres,et al.  Caveolin-1: an ambiguous partner in cell signalling and cancer , 2008, Journal of cellular and molecular medicine.

[28]  C. Waterman-Storer,et al.  Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases , 2007, The Journal of cell biology.

[29]  Raphael Zidovetzki,et al.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. , 2007, Biochimica et biophysica acta.

[30]  S. Ye,et al.  Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. , 2006, The American journal of pathology.

[31]  M. Westermann,et al.  Belt-like localisation of caveolin in deep caveolae and its re-distribution after cholesterol depletion , 2005, Histochemistry and Cell Biology.

[32]  Shu-Chun Lin,et al.  The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[33]  M. Sentjurc,et al.  Membrane fluidity characteristics of human lung cancer. , 1999, Cancer letters.

[34]  T. Salo,et al.  Human Tumor Tissue-Based 3D In Vitro Invasion Assays. , 2018, Methods in molecular biology.

[35]  I. Parmryd,et al.  Cholesterol depletion using methyl-β-cyclodextrin. , 2015, Methods in molecular biology.